124 filings
EFFECT
NBIO
Nascent Biotech Inc.
9 Apr 24
Notice of effectiveness
12:15am
S-1/A
NBIO
Nascent Biotech Inc.
IPO registration (amended)
3 Apr 24
5:10pm
S-1/A
NBIO
Nascent Biotech Inc.
IPO registration (amended)
29 Mar 24
2:53pm
S-1
NBIO
Nascent Biotech Inc.
IPO registration
14 Mar 24
9:14pm
10-Q
2024 Q3
NBIO
Nascent Biotech Inc.
Quarterly report
14 Feb 24
2:06pm
8-K
93d8mf91ib5387 r5
19 Dec 23
Other Events
8:00am
8-K
t53dipmkh9ph7
6 Sep 23
Other Events
1:54pm
NT 10-Q
8y8fc100 3bhb4d
14 Aug 23
Notice of late quarterly filing
4:00pm
8-K
97p1jiffeewp89
14 Jul 23
Other Events
2:37pm
8-K
yk4k udgan67sp
26 May 23
Termination of a Material Definitive Agreement
6:19pm
8-K
jfksvegap5vw0955
9 May 23
Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting
8:00am
8-K
pwb5puan
25 Jan 23
Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial
6:18pm
8-K
7r35fl1a xyc
28 Sep 22
Entry into a Material Definitive Agreement
4:00pm
EFFECT
et3 ur47phade
27 Sep 22
Notice of effectiveness
12:15am